Balyasny Asset Management
HLVX

Balyasny Asset Management’s HilleVax HLVX Stock Holding History

Balyasny Asset Management’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-976,297
Closed -$1.94M – 3139
2025
Q2 		$1.94M Sell
976,297
-26,520
-3% -$48.5K ﹤0.01% 1746
2025
Q1 		$1.45M Buy
1,002,817
+30
+0% +$55 ﹤0.01% 1847
2024
Q4 		$2.08M Sell
1,002,787
-12,057
-1% -$22.6K ﹤0.01% 1660
2024
Q3 		$1.79M Buy
+1,014,844
New +$2.6M ﹤0.01% 1719

Balyasny Asset Management's HLVX Position: Q3 2025 in Review

Balyasny Asset Management sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 976,297 shares — an estimated $1.94M sold.

Balyasny Asset Management first reported a position in HLVX in Q3 2024 and held it in 4 quarters. The position peaked at $2.08M in Q4 2024. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • Balyasny Asset Management reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 976,297 HilleVax shares in Q3 2025, an estimated $1.94M.
  • Balyasny Asset Management first reported a position in HilleVax in Q3 2024 and held it in 4 quarters.
  • Balyasny Asset Management's HilleVax position peaked at $2.08M in Q4 2024.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Balyasny Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.